Cas:733776-45-9 6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid manufacturer & supplier

Chemical Name:6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid

CAS.NO:733776-45-9

Synonyms:6-(2,4-DIMETHOXYPHENYL)NICOTINIC ACID;3-Pyridinecarboxylicacid,6-(2,4-dimethoxyphenyl);6-(2,4-Dimethoxyphenyl)pyridine-3-carboxylicacid

Molecular Formula:C₁₄H₁₃NO₄

Molecular Weight:259.25700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:68.65000

Exact Mass:259.08400

LogP:2.46400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-(2,4-DIMETHOXYPHENYL)NICOTINIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-(2,4-Dimethoxyphenyl)pyridine-3-carboxylicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyridinecarboxylicacid,6-(2,4-dimethoxyphenyl) Use and application,6-(2,4-Dimethoxyphenyl)pyridine-3-carboxylicacid technical grade,usp/ep/jp grade.

Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid manufacturer At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid supplier At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid vendor Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 6-(2,4-dimethoxyphenyl)pyridine-3-carboxylic acid factory Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.